top of page
  • Instagram
  • Facebook

Soy and Breast Cancer: What Does the Research Actually Show?

  • Writer: Megan Sandri
    Megan Sandri
  • 2 days ago
  • 8 min read

If you've ever been told to avoid soy because of breast cancer, you're not alone.


Soy has been the subject of considerable confusion over the years. The concern usually comes down to one question:

If soy contains compounds that can interact with estrogen receptors, could eating soy increase the risk of breast cancer—or cause an existing breast cancer to grow?


This is a particularly important question for people with hormone-sensitive or estrogen receptor-positive (ER+) breast cancer.


The good news is that the human evidence is much more reassuring than some of the early headlines suggested.


Current research does not show that eating soy foods increases the risk of breast cancer. In fact, studies in people with breast cancer suggest that consuming moderate amounts of soy may be associated with better outcomes, including a lower risk of recurrence and death from breast cancer. However, these findings are primarily based on observational research, so they do not prove that soy itself prevents recurrence.


So where did the concern about soy come from?


Bowl of milk with scattered soybeans and flowers on a dark textured surface, a calm rustic still life.

Why did people become concerned about soy and breast cancer?

Soy contains naturally occurring compounds called isoflavones.


Isoflavones are a type of phytoestrogen, meaning they are plant compounds with a chemical structure that is somewhat similar to human estrogen.


This led to an understandable—but overly simplistic—line of reasoning:

Soy contains phytoestrogens → phytoestrogens resemble estrogen → estrogen can stimulate some breast cancers → soy must increase breast cancer risk.

The problem is that isoflavones do not behave the same way as human estrogen.


Their interactions with estrogen receptors are more complicated, and their effects can vary depending on the tissue and biological context.


Much of the early concern also came from laboratory and animal research. Some studies in rodents suggested that soy isoflavones could stimulate estrogen-sensitive breast cancer cells.


However, rodents metabolize isoflavones differently from humans, and the effects observed in these experiments have not translated into evidence that eating soy increases breast cancer risk in people.


What does the research on soy and breast cancer show?

When we look at human research, the picture is considerably more reassuring.


Large observational studies have generally found no increased risk of breast cancer among people who consume soy foods.


Research in breast cancer survivors has gone a step further. Studies have found that people who consume soy after a breast cancer diagnosis do not appear to have worse outcomes, and some studies suggest that soy consumption may be associated with lower recurrence and improved overall survival.


The World Cancer Research Fund/American Institute for Cancer Research evidence review currently describes the evidence as limited suggestive for an association between soy foods and lower breast cancer recurrence and mortality.


That wording is important.


"Limited suggestive" does not mean that soy has been proven to prevent recurrence.


It means that the evidence is encouraging enough to be interesting, but there are still limitations to the research and we cannot establish cause and effect with confidence.


What about estrogen receptor-positive breast cancer?

This is often the biggest concern.


If someone has been diagnosed with an ER+ breast cancer, it can seem logical that a food containing phytoestrogens should be avoided.


However, human research has not shown that eating soy foods worsens outcomes in people with ER+ breast cancer.


Some observational research has even suggested that the potential association with improved outcomes may extend to people with hormone receptor-positive disease.


That doesn't mean soy should be considered a treatment for ER+ breast cancer.


It means that having an estrogen-sensitive cancer does not automatically mean you need to eliminate soy foods from your diet.


What about tamoxifen and aromatase inhibitors?

Another common concern is whether soy interacts with endocrine therapies such as tamoxifen or aromatase inhibitors.


Current population-based research has not demonstrated a harmful interaction between soy foods and anti-estrogen medications. Some observational studies have even suggested that soy consumption may be associated with particularly favourable outcomes among people taking these medications.


However, these findings should not be interpreted as evidence that soy makes these medications more effective.


And importantly, this research is primarily about soy foods, not high-dose soy isoflavone supplements.


If you're taking endocrine therapy, you should continue taking your prescribed medication as directed and discuss any concerns about diet or supplements with your oncology team.


Soy food is not the same as a soy supplement

This is one of the most important distinctions in the soy conversation.


The reassuring research on breast cancer largely involves soy foods, such as:

  • Tofu

  • Tempeh

  • Edamame

  • Soy milk

  • Soy yogurt

  • Soy nuts


These foods contain protein, fibre, vitamins, minerals, and a variety of naturally occurring plant compounds.


A concentrated soy isoflavone supplement is a very different exposure.


It can provide substantially higher amounts of isolated compounds than would typically be obtained from food, and we cannot automatically assume that research on soy foods applies to high-dose supplements.


For this reason, I would not interpret research showing that soy foods are safe as evidence that high-dose soy isoflavone supplementation is necessary or beneficial.


In fact, the AICR specifically cautions against using studies of soy foods to justify concentrated soy or isoflavone supplements.


How much soy is considered a serving?

There isn't a universally prescribed amount of soy that everyone with breast cancer should eat.


However, studies investigating soy consumption often describe moderate intake as approximately one to two servings per day.


Examples of a serving used in cancer research include approximately:

  • ⅓ cup tofu

  • ½ cup tempeh

  • ½ cup shelled edamame

  • 1 cup soy milk


Exact serving definitions vary between studies, so these numbers shouldn't be interpreted as a therapeutic dose.


The important point is that the research supporting the safety of soy generally reflects ordinary food consumption, rather than extremely high doses of isolated soy compounds.


What about soy protein?

Soy protein can be a useful source of protein, particularly for people following a plant-based diet.


Foods such as tofu, tempeh, edamame, and fortified soy milk can contribute meaningful amounts of protein while also providing other nutrients.


Soy protein powders and highly processed soy products are somewhat different from whole or minimally processed soy foods.


That doesn't necessarily make them "bad."


It simply means that when we're talking about the research on soy and breast cancer, we need to be clear about what type of soy was actually studied.


A dietary pattern containing a variety of whole and minimally processed plant foods is generally a more useful goal than trying to obtain a particular amount of isolated soy isoflavones.


What about soy milk?

Soy milk can be a perfectly reasonable part of a healthy dietary pattern.


If you're using soy milk as a dairy alternative, choosing an unsweetened, fortified product can be useful for providing nutrients such as calcium and vitamin D.


Soy milk can also be a convenient source of protein.


There is no good evidence that people with breast cancer need to avoid soy milk simply because it contains soy.


What about tofu and tempeh?

Both tofu and tempeh can be excellent sources of plant-based protein.


They can also be useful for people trying to reduce their intake of red and processed meat or simply increase the variety of plant foods in their diet.


Tempeh is fermented, while tofu is not, but both can fit comfortably within a varied dietary pattern.


Again, there is no evidence that people with breast cancer need to avoid these foods because of their soy content.


Does soy prevent breast cancer?

This is where it is important not to swing from one extreme to another.


The evidence does not support saying that:

"Soy prevents breast cancer."

Research examining soy consumption and breast cancer risk has produced mixed results, and the strength of evidence is not sufficient to recommend soy specifically as a breast cancer prevention strategy.


There are interesting hypotheses about why soy might potentially be protective, including effects of isoflavones on estrogen signalling, inflammation, and other cellular pathways.


But these mechanisms are still being studied.


The strongest practical conclusion is simpler:

There is no good reason to avoid soy because of fear that it causes breast cancer.


What about soy after a breast cancer diagnosis?

This is where the evidence is particularly reassuring.


Current evidence does not show that eating soy foods after a breast cancer diagnosis increases the risk of recurrence.


In fact, observational studies suggest that moderate soy intake may be associated with lower recurrence and better overall survival.


The most recent AICR/WCRF evidence review concluded that there is no evidence that soy foods are harmful after a breast cancer diagnosis, while the evidence suggesting potential benefit remains limited.


So if you already enjoy tofu, tempeh, edamame, or soy milk:

There is no evidence-based reason to eliminate them simply because you have had breast cancer.


What if I didn't eat soy before my diagnosis?

This is a slightly different question.


The current evidence does not support telling someone who has never eaten soy that they need to start consuming it specifically to prevent breast cancer recurrence.


The WCRF/AICR guidance notes that the evidence is not strong enough to recommend introducing soy foods after diagnosis as a specific cancer-prevention strategy. However, people who already eat soy do not need to stop.


In other words:

You don't need to start eating soy because you have breast cancer—but you also don't need to stop eating it because you have breast cancer.


If you enjoy soy and it fits into your overall dietary pattern, it can be a nutritious food choice.


So why does the internet still say to avoid soy?

Part of the problem is that information about soy often combines very different types of research.


A headline might refer to:

  • A cell study

  • An animal study

  • A concentrated isoflavone supplement

  • A soy protein powder

  • A whole soy food

  • A population study

  • A clinical trial


These aren't interchangeable.


A laboratory study showing that a concentrated compound affects breast cancer cells does not tell us what happens when someone eats tofu.


Likewise, an observational study showing that people who eat soy have better outcomes doesn't prove that soy itself caused those outcomes.


Understanding the type of evidence is just as important as knowing the result.


The bigger picture: soy as part of a healthy dietary pattern

It can be tempting to focus on individual foods when thinking about cancer.


But your overall dietary pattern is likely much more important than whether you eat one particular food.


Soy foods can contribute:

  • Plant-based protein

  • Fibre

  • Unsaturated fats

  • Vitamins and minerals

  • A variety of phytochemicals


They can also be a practical replacement for some animal protein sources.


For someone following a plant-based diet, soy can be particularly useful because it provides a relatively concentrated source of high-quality protein.


Rather than asking whether soy is a "cancer food," I think a more useful question is:


How does soy fit into the overall dietary pattern that supports this person's health?


The bottom line

The idea that people with breast cancer should avoid soy is not supported by current human evidence.


Soy foods contain isoflavones, which interact with estrogen pathways differently from human estrogen. Concerns about soy originally arose in part from laboratory and animal research, but these effects have not been demonstrated in humans eating soy foods.


For people who have already been diagnosed with breast cancer, research does not show that moderate soy consumption increases recurrence risk. Some observational evidence even suggests potential benefits for recurrence and survival, although this evidence is not strong enough to say that soy prevents recurrence.


The distinction between soy foods and concentrated soy/isoflavone supplements is important.


So if you enjoy tofu, tempeh, edamame, or soy milk, there is no need to fear them because of breast cancer.


Soy doesn't need to be a source of confusion. It can simply be one nutritious part of a varied dietary pattern.


Interested in nutrition during or after cancer treatment?

Nutrition can play an important role throughout cancer treatment and survivorship. An individualized approach can help you navigate dietary changes, nutritional needs, symptoms, supplements, and long-term health goals.


Important note

This article is intended for general educational purposes and does not replace individualized medical advice or cancer treatment. Dietary recommendations should be considered in the context of your overall health, cancer history, treatment plan, medications, and nutritional needs.

Comments


bottom of page